Impact of the Covid-19 pandemic on perinatal mental health (Riseup-PPD-COVID-19): protocol for an international prospective cohort study

Emma Motrico, Rena Bina, Sara Domínguez-Salas, Vera Mateus, Yolanda Contreras-García, Mercedes Carrasco-Portiño, Erilda Ajaz, Gisele Apter, Andri Christoforou, Pelin Dikmen-Yildiz, Ethel Felice, Camellia Hancheva, Eleni Vousoura, Claire A Wilson, Rachel Buhagiar, Carmen Cadarso-Suárez, Raquel Costa, Emmanuel Devouche, Ana Ganho-Ávila, Diego Gómez-Baya, Francisco Gude, Eleni Hadjigeorgiou, Drorit Levy, Ana Osorio, María Fe Rodriguez, Sandra Saldivia, María Fernanda González, Marina Mattioli, Ana Mesquita, Riseup-PPD-COVID-19 Group, Emma Motrico, Rena Bina, Sara Domínguez-Salas, Vera Mateus, Yolanda Contreras-García, Mercedes Carrasco-Portiño, Erilda Ajaz, Gisele Apter, Andri Christoforou, Pelin Dikmen-Yildiz, Ethel Felice, Camellia Hancheva, Eleni Vousoura, Claire A Wilson, Rachel Buhagiar, Carmen Cadarso-Suárez, Raquel Costa, Emmanuel Devouche, Ana Ganho-Ávila, Diego Gómez-Baya, Francisco Gude, Eleni Hadjigeorgiou, Drorit Levy, Ana Osorio, María Fe Rodriguez, Sandra Saldivia, María Fernanda González, Marina Mattioli, Ana Mesquita, Riseup-PPD-COVID-19 Group

Abstract

Background: Corona Virus Disease 19 (COVID-19) is a new pandemic, declared a public health emergency by the World Health Organization, which could have negative consequences for pregnant and postpartum women. The scarce evidence published to date suggests that perinatal mental health has deteriorated since the COVID-19 outbreak. However, the few studies published so far have some limitations, such as a cross-sectional design and the omission of important factors for the understanding of perinatal mental health, including governmental restriction measures and healthcare practices implemented at the maternity hospitals. Within the Riseup-PPD COST Action, a study is underway to assess the impact of COVID-19 in perinatal mental health. The primary objectives are to (1) evaluate changes in perinatal mental health outcomes; and (2) determine the risk and protective factors for perinatal mental health during the COVID-19 pandemic. Additionally, we will compare the results between the countries participating in the study.

Methods: This is an international prospective cohort study, with a baseline and three follow-up assessments over a six-month period. It is being carried out in 11 European countries (Albania, Bulgaria, Cyprus, France, Greece, Israel, Malta, Portugal, Spain, Turkey, and the United Kingdom), Argentina, Brazil and Chile. The sample consists of adult pregnant and postpartum women (with infants up to 6 months of age). The assessment includes measures on COVID-19 epidemiology and public health measures (Oxford COVID-19 Government Response Tracker dataset), Coronavirus Perinatal Experiences (COPE questionnaires), psychological distress (BSI-18), depression (EPDS), anxiety (GAD-7) and post-traumatic stress symptoms (PTSD checklist for DSM-V).

Discussion: This study will provide important information for understanding the impact of the COVID-19 pandemic on perinatal mental health and well-being, including the identification of potential risk and protective factors by implementing predictive models using machine learning techniques. The findings will help policymakers develop suitable guidelines and prevention strategies for perinatal mental health and contribute to designing tailored mental health interventions.

Trial registration: ClinicalTrials.gov Identifier: NCT04595123 .

Keywords: Anxiety; COVID-19; Coping mechanisms; Depression; Post-traumatic stress disorders; Postpartum; Pregnancy; Risk factors.

Conflict of interest statement

The authors declare that they have no competing interest.

References

    1. The Royal College of Obstetricians and Gynaecologists. Information for healthcare professionals Coronavirus (COVID-19) infection and abortion care. 2020. . Accessed 21 Jun 2020.
    1. Smith V, Seo D, Warty R, Payne O, Salih M, Chin KL, et al. Maternal and neonatal outcomes associated with COVID-19 infection: a systematic review. PLoS One. 2020;15:e0234187. doi: 10.1371/journal.pone.0234187.
    1. Prabhu M, Cagino K, Matthews K, Friedlander R, Glynn S, Kubiak J, et al. Pregnancy and postpartum outcomes in a universally tested population for SARS-CoV-2 in new York City: a prospective cohort study. BJOG An Int J Obstet Gynaecol. 2020;127:1548–1556. doi: 10.1111/1471-0528.16403.
    1. Docherty AB, Harrison EM, Green CA, Hardwick H, Pius R, Norman L, et al. Features of 16,749 hospitalised UK patients with COVID-19 using the ISARIC WHO clinical characterisation protocol. JS Nguyen-Van-Tam. 2020;10:2020.04.23.20076042. 10.1101/2020.04.23.20076042.
    1. Rodríguez-Blanco N, Vegara-Lopez I, Aleo-Giner L, Tuells J. Scoping review of coronavirus case series (SARS-CoV, MERS-CoV and SARS-CoV-2) and their obstetric and neonatal results. Revista Espanola de Quimioterapia. 2020;33:313–26. 10.37201/req/064.2020.
    1. Lamouroux A, Attie-Bitach T, Martinovic J, Leruez-Ville M, Ville Y. Evidence for and against vertical transmission for severe acute respiratory syndrome coronavirus 2. Am J Obstet Gynecol. 2020;223:91. doi: 10.1016/j.ajog.2020.04.039.
    1. Woodworth KR, Olsen EO, Neelam V, Lewis EL, Galang RR, Oduyebo T, et al. Birth and Infant Outcomes Following Laboratory-Confirmed SARS-CoV-2 Infection in Pregnancy — SET-NET, 16 Jurisdictions, March 29–October 14, 2020. MMWR Morb Mortal Wkly Rep. 2020;69:1635–1640. doi: 10.15585/mmwr.mm6944e2.
    1. Rocca-Ihenacho L, Alonso C. Where do women birth during a pandemic? Changing perspectives on Safe Motherhood during the COVID-19 pandemic. J Glob Heal Sci. 2020;2. 10.35500/jghs.2020.2.e4.
    1. Thapa SB, Mainali A, Schwank SE, Acharya G. Maternal mental health in the time of the COVID-19 pandemic. Acta Obstet Gynecol Scand. 2020;99:817–818. doi: 10.1111/aogs.13894.
    1. Topalidou A, Thomson G, Downe S. COVID-19 and maternal mental health: Are we getting the balance right? medRxiv. 2020;2020 03.30.20047969. 10.1101/2020.03.30.20047969.
    1. Motrico E, Mateus V, Bina R, Felice E, Bramante A, Kalcev G, et al. Good practices in perinatal mental health during the COVID-19 pandemic: a report from task-force RISEUP-PPD COVID-19. Clínica y Salud. 2020;31:155–160. doi: 10.5093/clysa2020a26.
    1. Hahn-Holbrook J, Cornwell-Hinrichs T, Anaya I. Economic and Health Predictors of National Postpartum Depression Prevalence: A Systematic Review, Meta-analysis, and Meta-Regression of 291 Studies from 56 Countries. Front Psychiatry. 2018;8. 10.3389/fpsyt.2017.00248.
    1. Shorey S, Chee CYI, Ng ED, Chan YH, Tam WWS, Chong YS. Prevalence and incidence of postpartum depression among healthy mothers: a systematic review and meta-analysis. J Psychiatr Res. 2018;104:235–248. doi: 10.1016/j.jpsychires.2018.08.001.
    1. Fawcett EJ, Fairbrother N, Cox ML, White IR, Fawcett JM. The prevalence of anxiety disorders during pregnancy and the postpartum period. J Clin Psychiatry. 2019;80. 10.4088/JCP.18r12527.
    1. Andersen LB, Melvaer LB, Videbech P, Lamont RF, Joergensen JS. Risk factors for developing post-traumatic stress disorder following childbirth: a systematic review. Acta Obstet Gynecol Scand. 2012;91:1261–1272. doi: 10.1111/j.1600-0412.2012.01476.x.
    1. Bauer A, Parsonage M, Knapp M, Lemmi V, Adelaja B. The costs of perinatal mental health problems. LSE Cent Ment Heal. 2014:1–44. .
    1. Lebel C, MacKinnon A, Bagshawe M, Tomfohr-Madsen L, Giesbrecht G. Elevated depression and anxiety symptoms among pregnant individuals during the COVID-19 pandemic. J Affect Disord. 2020;277:5–13. doi: 10.1016/j.jad.2020.07.126.
    1. Wu Y, Zhang C, Liu H, Duan C, Li C, Fan J, et al. Perinatal depressive and anxiety symptoms of pregnant women along with COVID-19 outbreak in China. Am J Obstet Gynecol. 2020;0. 10.1016/j.ajog.2020.05.009.
    1. Durankuş F, Aksu E. Effects of the COVID-19 pandemic on anxiety and depressive symptoms in pregnant women: a preliminary study. J Matern Neonatal Med. 2020:1–7. 10.1080/14767058.2020.1763946.
    1. Kahyaoglu Sut H, Kucukkaya B. Anxiety, depression, and related factors in pregnant women during the COVID-19 pandemic in Turkey: a web-based cross-sectional study. Perspect Psychiatr Care. 2020. 10.1111/ppc.12627.
    1. Saccone G, Florio A, Aiello F, Venturella R, Chiara De Angelis M, Locci M, et al. Psychological impact of coronavirus disease 2019 in pregnant women. Am J Obstet Gynecol. 2020. 10.1016/j.ajog.
    1. Holmes EA, O’Connor RC, Perry VH, Tracey I, Wessely S, Arseneault L, et al. Multidisciplinary research priorities for the COVID-19 pandemic: a call for action for mental health science. Lancet Psychiatry. 2020;7:547–560. doi: 10.1016/S2215-0366(20)30168-1.
    1. Fonseca A, Ganho-Ávila A, Lambregtse-van den Berg M, Lupattelli A, de la Fé Rodriguez-Muñoz M, Ferreira P, et al. Emerging issues and questions on peripartum depression prevention, diagnosis and treatment: a consensus report from the cost action riseup-PPD. J Affect Disord. 2020;274:167–173. doi: 10.1016/j.jad.2020.05.112.
    1. Curry SJ, Krist AH, Owens DK, Barry MJ, Caughey AB, Davidson KW, et al. Interventions to prevent perinatal depression. JAMA. 2019;321:580. doi: 10.1001/jama.2019.0007.
    1. Field T. Postpartum depression effects, risk factors and interventions: a review. Clin Depress. 2017;03:1–13. doi: 10.4172/2572-0791.1000122.
    1. Kinser PA, Thacker LR, Lapato D, Wagner S, Roberson-Nay R, Jobe-Shields L, et al. Depressive symptom prevalence and predictors in the first half of pregnancy. J Women’s Heal. 2018;27:369–76. 10.1089/jwh.2017.6426.
    1. Houston KA, Kaimal AJ, Nakagawa S, Gregorich SE, Yee LM, Kuppermann M. Mode of delivery and postpartum depression: The role of patient preferences. Am J Obstet Gynecol. 2015;212:229 e1–229.e7. 10.1016/j.ajog.2014.09.002.
    1. Putnam K, Robertson-Blackmore E, Sharkey K, Payne J, Bergink V, Munk-Olsen T, et al. Heterogeneity of postpartum depression: a latent class analysis. Lancet Psychiatry. 2015;2:59–67. 10.1016/S2215-0366(14)00055-8.
    1. Yim I, Tanner Stapleton L, Guardino C, Hahn-Holbrook J, Dunkel SC. Biological and psychosocial predictors of postpartum depression: systematic review and call for integration. SSRN. 2015;11:99–137. 10.1146/annurev-clinpsy-101414-020426.
    1. Roser M, Ritchie H, Ortiz E, Hassel J. Coronavirus Pandemic (COVID-19) - Statistics and Research - Our World in Data. . Accessed 3 Dec 2020.
    1. Thomason ME, Graham A, VanTieghem MR. COPE: Coronavirus Perinatal Experiences - Impact Survey (COPE-IS). 2020. Retrieved from .
    1. Thomason ME, Graham A, Smyser CD, Rogers CE. COPE: Coronavirus Perinatal Experiences– Impact Update (COPE-IU). 2020. Retrieved from .
    1. Thomason M, Graham A. COPE: Coronavirus Perinatal Experiences – Care Follow-up (COPE-CF). 2020. Retrieved from: .
    1. Derogatis L. BSI, brief symptom inventory: administration, scoring & procedures manual. Minneapolis MN: National Computer Systems; 1993.
    1. Cox JL, Holden JM, Sagovsky R. Detection of Postnatal Depression: Development of the 10-item Edinburgh Postnatal Depression scale. Br J Psychiatry. 1987;150:782–786. doi: 10.1192/bjp.150.6.782.
    1. Cox J. Thirty years with the Edinburgh postnatal depression scale: voices from the past and recommendations for the future. Br J Psychiatry. 2019;214:127–129. doi: 10.1192/bjp.2018.245.
    1. Levis B, Negeri Z, Sun Y, Benedetti A, Thombs BD. Accuracy of the Edinburgh postnatal depression scale (EPDS) for screening to detect major depression among pregnant and postpartum women: systematic review and meta-analysis of individual participant data. BMJ. 2020;371:m4022. doi: 10.1136/bmj.m4022.
    1. Gibson J, McKenzie-McHarg K, Shakespeare J, Price J, Gray R. A systematic review of studies validating the Edinburgh postnatal depression scale in antepartum and postpartum women. Acta Psychiatr Scand. 2009;119:350–364. doi: 10.1111/j.1600-0447.2009.01363.x.
    1. Mann R, Evans J. Identifying Perinatal Depression and Anxiety. Chichester, UK: John Wiley & Sons, Ltd; 2015. Screening Tools and Methods of Identifying Perinatal Depression; pp. 76–92.
    1. Spitzer RL, Kroenke K, Williams JBW, Löwe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166:1092–1097. doi: 10.1001/archinte.166.10.1092.
    1. American Psychiatric Association . Diagnostic and Statistical Manual of Mental Disorders. Washington, DC: Fifth Edition American Psychiatric Association; 2013.
    1. Moreno-Peral P, De Dios LJ, Marston L, King M, Nazareth I, Motrico E, et al. Predicting the onset of anxiety syndromes at 12 months in primary care attendees. The predictA-Spain study. PLoS One. 2014;9. 10.1371/journal.pone.0106370.
    1. Moreno-Peral P, Conejo-Cerón S, Rubio-Valera M, Fernández A, Navas-Campaña D, Rodríguez-Morejón A, et al. Effectiveness of psychological and/or educational interventions in the prevention of anxiety: a systematic review, meta-analysis, and meta-regression. JAMA Psychiatry. 2017;74:1021–9. 10.1001/jamapsychiatry.2017.2509.
    1. National Collaborating Centre for Mental Health. Antenatal and postnatal mental health. The NICE guideline on clinical management and service guidance[NICE Clinical Guidelines, no. 45]. London (UK): British Psychological Society and Royal College of Psychiatrists; 2007.
    1. Simpson W, Glazer M, Michalski N, Steiner M, Frey BN. Comparative efficacy of the generalized anxiety disorder 7-item scale and the Edinburgh postnatal depression scale as screening tools for generalized anxiety disorder in pregnancy and the postpartum period. Can J Psychiatr. 2014;59:434–440. doi: 10.1177/070674371405900806.
    1. Fairbrother N, Corbyn B, Thordarson DS, Ma A, Surm D. Screening for perinatal anxiety disorders: room to grow. J Affect Disord. 2019;250:363–370. doi: 10.1016/j.jad.2019.03.052.
    1. Blevins CA, Weathers FW, Davis MT, Witte TK, Domino JL. The posttraumatic stress disorder checklist for DSM-5 (PCL-5): development and initial psychometric evaluation. J Trauma Stress. 2015;28:489–98. 10.1002/jts.22059.
    1. Weathers FW, Litz BT, Keane TM, Palmieri PA, Marx BP, Schnurr PP. PTSD checklist for DSM-5 (PCL-5) - standard [measurement instrument]. 2013. . Accessed 22 Oct 2020.
    1. Collins GS, Reitsma JB, Altman DG, Moons KG. Transparent Reporting of a Multivariable Prediction Model for Individual Prognosis or Diagnosis (TRIPOD): the TRIPOD statement. Ann Intern Med. 2015;162(1):55–63. 10.7326/M14-0697.
    1. Vandenbroucke JP, Von Elm E, Altman DG, Gøtzsche PC, Mulrow CD, Pocock SJ, et al. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and Elaboration. PLoS Med. 2007;4. 10.1371/journal.pmed.
    1. COVID-19 Mental Health | DEPRESSD Project. . Accessed 1 Nov 2020.
    1. Tortajada S, García-Gómez JM, Vicente J, Sanjuán J, De Frutos R, Martín-Santos R, et al. Prediction of postpartum depression using multilayer perceptrons and pruning. Methods Inf Med. 2009;48:291–298. doi: 10.3414/ME0562.
    1. Zhang Y, Wang S, Hermann A, Joly R, Pathak J. Development and validation of a machine learning algorithm for predicting the risk of postpartum depression among pregnant women. J Affect Disord. 2021;279:1–8. 10.1016/j.jad.2020.09.113.
    1. Shin D, Lee KJ, Adeluwa T, Hur J. Clinical Medicine Machine Learning-Based Predictive Modeling of Postpartum Depression doi:10.3390/jcm9092899.
    1. Pierce M, McManus S, Jessop C, John A, Hotopf M, Ford T, et al. Says who? The significance of sampling in mental health surveys during COVID-19. Lancet Psychiatry. 2020;7:567–568. doi: 10.1016/S2215-0366(20)30237-6.

Source: PubMed

Patrocinadores e Colaboradores

Condições médicas

Intervenções de drogas

3
Se inscrever